Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Q In pregnant women at risk, is prophylactic use of antiplatelet agents (such as aspirin and dipyridamole) effective for preventing or delaying the development of pre-eclampsia as well as other related maternal and child outcomes?
Clinical impact ratings FP/GP/Obstetrics ★★★★★★☆ Obstetrics ★★★★★★☆
the Cochrane Pregnancy and Childbirth Group trials register (September 2003), the Cochrane Central Register of Controlled Trials (Cochrane Library, Issue 2, 2003), EMBASE/Excerpta Medica (1994–2003), and congress proceedings of the International and European Societies for the Study of Hypertension in Pregnancy (up to 2002).
Study selection and assessment:
randomised controlled trials (RCTs) that compared any antiplatelet agent (such as low dose aspirin or dipyridamole) with a control condition comprising placebo or no antiplatelet agent in pregnant women considered to be at risk of developing pre-eclampsia. Exclusion criteria included comparisons of 1 antiplatelet agent with another, and of antiplatelets with other interventions. Study quality was assessed …